Chemo May Kill Without This Test First: Why DPYD Screening Should Be Mandatory
One woman’s death sparks fresh urgency for genetic testing before common chemotherapy drugs like 5-FU and capecitabine
Topline
Routine genetic testing before starting chemotherapy with capecitabine or 5-FU could prevent hundreds of avoidable deaths each year. Yet most patients in the U.S. still begin treatment without being screened for DPD enzyme deficiency, a known risk factor for life-threatening toxicity.
Study Details
The issue came to national attention after the dea…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.